George Dakwar in Glen Mills, Pennsylvania

Home Pennsylvania Glen Mills

George Dakwar has Urology as his primary medical specialty. Their primary office is: 500 Evergreen Dr G5 Garden Terrace in Glen Mills, Pennsylvania.

They're a part of the: Centers For Advanced Urology Llc medical group which has around 83 members. You can call their office at 610-579-3577 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Rutgers New Jersey Medical School and graduated in 2003 (around 21 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

George Dakwar Office Phone and Directions

George Dakwar
Centers For Advanced Urology Llc
500 Evergreen Dr G5 Garden Terrace
Glen Mills, Pennsylvania 19342
610-579-3577

Patient Ratings
Please rate your experience with George Dakwar below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 610-579-3577

Enter a starting address:

Healthcare Info for George Dakwar

Medical School: Rutgers New Jersey Medical School
Graduation Year: 2003
The Primary Medical Specialty for George Dakwar is listed as: Urology
Approximate Years of Experience: 21
PAC (PECOS ID)#: 0648316398
NPI #: 1366609448
NPI Created On: 05/17/2008
NPI Last Updated Listed as: 01/20/2016
Primary Taxonomy Code: 208800000X
License Number:
MD437754
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

AmeriHealth New Jersey
Blue Cross Blue Shield
Highmark Health Insurance Company
AmeriHealth HMO, Inc.
Humana
Highmark Inc.
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: Spanish, English.

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Bladder irrigation and/or instillation
Insertion of temporary bladder catheter
Bladder instillation of cancer preventive, inhibiting, or suppressive agent
Electronic assessment of bladder emptying
Ultrasound measurement of bladder capacity after voiding
Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope
Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope
Removal of foreign body, stone, or stent from bladder canal (urethra) or bladder using an endoscope
Biopsy of prostate gland
Imaging of urinary tract
Ultrasound of rectum
Automated urinalysis test
Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle
Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle
New patient office or other outpatient visit, typically 45 minutes
Established patient office or other outpatient visit, typically 10 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $106

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788161033

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56

Payments Total: $85

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788161007

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788161009

Being Disputed:: No

Product Related: No

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788161011

Being Disputed:: No

Product Related: No

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788161013

Being Disputed:: No

Product Related: No

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788161017

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788161015

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788161019

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $10

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788161021

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788161023

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Urology Professionals in Glen Mills

1.
Cara O'brien

500 Evergreen Dr G5 Garden Terrace
Glen-mills, PA
Centers For Advanced Urology Llc

2.
Cara O'brien

100 Maris Grove Way
Glen-mills, PA
Centers For Advanced Urology Llc

3.
Lynn Paik

500 Evergreen Dr G5 Garden Terrace
Glen-mills, PA
Centers For Advanced Urology Llc

Providers in Centers For Advanced Urology Llc

1.Max Ahn Md

100 E Lancaster Ave
Wynnewood Pa 19096-3433
Centers For Advanced Urology Llc
Urology

2.Caitlin Alsdorf

8815 Germantown Ave
Philadelphia Pa 19118-2722
Centers For Advanced Urology Llc
Nurse Practitioner

3.Melanie Amster

1 Presidential Blvd
Bala Cynwyd Pa 19004-1017
Centers For Advanced Urology Llc
Urology

4.Melanie Amster

231 N Broad St Fl
Philadelphia Pa 19107-1511
Centers For Advanced Urology Llc
Urology

5.Donald Andersen

915 Old Fern Hill Rd
West Chester Pa 19380-4269
Centers For Advanced Urology Llc
Urology

6.Elizabeth Anoia-loftus Md

1800 Byberry Rd
Huntingdon Valley Pa 19006-3524
Centers For Advanced Urology Llc
Urology

View all 83 members of Centers For Advanced Urology Llc medical group